Emilie Gunn
@emiliemgunn.bsky.social
Journals Director @ ASCO, President @ Council of Science Editors, mom, reader, cook, knitter, Girl Scouts leader, runner, general lover of words. All views are mine.
Reposted by Emilie Gunn
Publish with JCO GO or JCO OA. Advantages of fully #OpenAccess journals include:
More citations & downloads
Greater engagement
A wider opportunity to advance cancer care globally
Compliance with funder mandates
With International #OAWeek coming up, learn how you can expand your reach.
More citations & downloads
Greater engagement
A wider opportunity to advance cancer care globally
Compliance with funder mandates
With International #OAWeek coming up, learn how you can expand your reach.
October 23, 2025 at 2:14 PM
Publish with JCO GO or JCO OA. Advantages of fully #OpenAccess journals include:
More citations & downloads
Greater engagement
A wider opportunity to advance cancer care globally
Compliance with funder mandates
With International #OAWeek coming up, learn how you can expand your reach.
More citations & downloads
Greater engagement
A wider opportunity to advance cancer care globally
Compliance with funder mandates
With International #OAWeek coming up, learn how you can expand your reach.
Reposted by Emilie Gunn
Check out the article in JCO on the Metformin Active Surveillance Trial in Low-Risk Prostate Cancer. Learn about the latest research on this common drug's potential role in managing prostate cancer: brnw.ch/21wX6DG
October 31, 2025 at 6:45 PM
Check out the article in JCO on the Metformin Active Surveillance Trial in Low-Risk Prostate Cancer. Learn about the latest research on this common drug's potential role in managing prostate cancer: brnw.ch/21wX6DG
@councilscienceed.bsky.social (CSE) is offering our virtual Short Course on Pub Management on 10/31/25. The agenda is full of everything you need to know to make your publication the best it can be.
15% off if you also reg for the CSE Fall Symposium!
www.councilscienceeditors.org/short-courses
15% off if you also reg for the CSE Fall Symposium!
www.councilscienceeditors.org/short-courses
Short Courses
www.councilscienceeditors.org
October 3, 2025 at 5:09 PM
@councilscienceed.bsky.social (CSE) is offering our virtual Short Course on Pub Management on 10/31/25. The agenda is full of everything you need to know to make your publication the best it can be.
15% off if you also reg for the CSE Fall Symposium!
www.councilscienceeditors.org/short-courses
15% off if you also reg for the CSE Fall Symposium!
www.councilscienceeditors.org/short-courses
Now available!! 🎧
Listen in to JCO OP's latest podcast, Promoting Resilience in Adolescents and Young Adults (AYAs) with Cancer via Developmentally Targeted, Evidence-Based Interventions | Podcast | ASCO Publications ascopubs.org/do/promoting...
Listen in to JCO OP's latest podcast, Promoting Resilience in Adolescents and Young Adults (AYAs) with Cancer via Developmentally Targeted, Evidence-Based Interventions | Podcast | ASCO Publications ascopubs.org/do/promoting...
Promoting Resilience in Adolescents and Young Adults (AYAs) with Cancer via Developmentally Targeted, Evidence-Based Interventions | Podcast | ASCO Publications
An estimated 85k adolescents and young adults (AYAs) between the ages of 15 to 39 will be diagnosed with cancer in the United States this year. AYAs with advanced cancer face care gaps for psychosocia...
ascopubs.org
August 20, 2025 at 3:51 PM
Now available!! 🎧
Listen in to JCO OP's latest podcast, Promoting Resilience in Adolescents and Young Adults (AYAs) with Cancer via Developmentally Targeted, Evidence-Based Interventions | Podcast | ASCO Publications ascopubs.org/do/promoting...
Listen in to JCO OP's latest podcast, Promoting Resilience in Adolescents and Young Adults (AYAs) with Cancer via Developmentally Targeted, Evidence-Based Interventions | Podcast | ASCO Publications ascopubs.org/do/promoting...
Emerging Trends in Point-of-Care Technology Development for Oncology in Low- and Middle-Income Countries | JCO Global Oncology ascopubs.org/doi/10.1200/...
Emerging Trends in Point-of-Care Technology Development for Oncology in Low- and Middle-Income Countries | JCO Global Oncology
The growing cancer burden and suboptimal diagnostic capacity in low- and middle-income
countries calls for urgent innovation in diagnostic solutions. Point-of-care technologies
(POCTs) offer a transfo...
ascopubs.org
July 1, 2025 at 3:10 PM
Emerging Trends in Point-of-Care Technology Development for Oncology in Low- and Middle-Income Countries | JCO Global Oncology ascopubs.org/doi/10.1200/...
Listen to the latest JCO Oncology Practice podcast, in which @fumikochino.bsky.social discusses barriers to cancer care that seem minor (e.g. paying for park) but are definitely not. ascopubs.org/do/park-park...
Park the Parking: Patient and Caregiver Perspectives on Transportation Barriers in Cancer | Podcast | ASCO Publications
Frustrations regarding the costs and difficulties with parking at hospitals is a common concern voiced by patients, families, and healthcare providers. Transportation barriers to receiving cancer care...
ascopubs.org
June 18, 2025 at 2:49 PM
Listen to the latest JCO Oncology Practice podcast, in which @fumikochino.bsky.social discusses barriers to cancer care that seem minor (e.g. paying for park) but are definitely not. ascopubs.org/do/park-park...
Stay connected to JCO Journals during #ASCO25! www.asco.org/annual-meeti...
JCO Central - ASCO
www.asco.org
May 31, 2025 at 8:33 PM
Stay connected to JCO Journals during #ASCO25! www.asco.org/annual-meeti...
Reposted by Emilie Gunn
Stop by JCO central while at ASCO. Enjoy the coffee, meet the editors and staff, learn more about JCO
May 31, 2025 at 5:28 PM
Stop by JCO central while at ASCO. Enjoy the coffee, meet the editors and staff, learn more about JCO
Simultaneous Publication in #JCOOP. #ASCO25
Educational Impact of a Podcast Curriculum for Hematology/Oncology Fellows: Final Results of the Multicenter Cluster Randomized PODCAST-HOF Trial | JCO Oncology Practice ascopubs.org/doi/10.1200/...
Educational Impact of a Podcast Curriculum for Hematology/Oncology Fellows: Final Results of the Multicenter Cluster Randomized PODCAST-HOF Trial | JCO Oncology Practice ascopubs.org/doi/10.1200/...
Educational Impact of a Podcast Curriculum for Hematology/Oncology Fellows: Final Results of the Multicenter Cluster Randomized PODCAST-HOF Trial | JCO Oncology Practice
PURPOSEMedical podcast integration into hematology/oncology fellowship curricula remains
largely unstudied. We conducted a multicenter cluster randomized trial to evaluate
the educational impact of a ...
ascopubs.org
May 31, 2025 at 6:51 PM
Simultaneous Publication in #JCOOP. #ASCO25
Educational Impact of a Podcast Curriculum for Hematology/Oncology Fellows: Final Results of the Multicenter Cluster Randomized PODCAST-HOF Trial | JCO Oncology Practice ascopubs.org/doi/10.1200/...
Educational Impact of a Podcast Curriculum for Hematology/Oncology Fellows: Final Results of the Multicenter Cluster Randomized PODCAST-HOF Trial | JCO Oncology Practice ascopubs.org/doi/10.1200/...
Reposted by Emilie Gunn
‼️ #ASCO25 simultaneous publication by Jacobs et al:
BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation. Read the full article: ascopubs.org/doi/10.1200/...
BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation. Read the full article: ascopubs.org/doi/10.1200/...
May 30, 2025 at 6:00 PM
‼️ #ASCO25 simultaneous publication by Jacobs et al:
BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation. Read the full article: ascopubs.org/doi/10.1200/...
BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation. Read the full article: ascopubs.org/doi/10.1200/...
Read all about it! Simultaneous Publication out now in JCO:
BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation | Journal of Clinical Oncology ascopubs.org/doi/10.1200/...
BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation | Journal of Clinical Oncology ascopubs.org/doi/10.1200/...
BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation
PURPOSEFamily and friend caregivers of patients undergoing hematopoietic stem-cell transplantation
(HSCT) struggle with immense caregiving burden, leading to substantial quality of
life (QOL) impairme...
ascopubs.org
May 30, 2025 at 4:23 PM
Read all about it! Simultaneous Publication out now in JCO:
BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation | Journal of Clinical Oncology ascopubs.org/doi/10.1200/...
BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation | Journal of Clinical Oncology ascopubs.org/doi/10.1200/...
Reposted by Emilie Gunn
Psst ... want to see how we're brewing up #ASCO25? We're busy behind the scenes making sure everything's just right! Can't WAIT to officially open the doors, welcome everyone, and get this Annual Meeting party started! See you there!
May 29, 2025 at 7:43 PM
Psst ... want to see how we're brewing up #ASCO25? We're busy behind the scenes making sure everything's just right! Can't WAIT to officially open the doors, welcome everyone, and get this Annual Meeting party started! See you there!
Pregnancy and Breast Cancer | Podcast | ASCO Publications ascopubs.org/do/pregnancy...
Pregnancy and Breast Cancer | Podcast | ASCO Publications
Dr. Chino talks with Dr. Erin Roesch and patient advocate Julia Maues about pregnancy associated cancer with a focus on breast cancer, the most common cancer diagnosed during pregnancy. This discussio...
ascopubs.org
May 23, 2025 at 5:47 PM
Pregnancy and Breast Cancer | Podcast | ASCO Publications ascopubs.org/do/pregnancy...
Time to Treatment Initiation for the 30 Most Prevalent Cancer Types: Trends and Predictors of Change | JCO Oncology Practice ascopubs.org/doi/10.1200/...
Time to Treatment Initiation for the 30 Most Prevalent Cancer Types: Trends and Predictors of Change | JCO Oncology Practice
PURPOSEAs the complexity and need for cancer care services continue to grow, time to treatment
initiation (TTI) has been increasing across cancer types. Presently there are no comprehensive
analyses i...
ascopubs.org
May 22, 2025 at 3:53 PM
Time to Treatment Initiation for the 30 Most Prevalent Cancer Types: Trends and Predictors of Change | JCO Oncology Practice ascopubs.org/doi/10.1200/...
Reposted by Emilie Gunn
Use of Large Language Models in Clinical Cancer Research | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10....
ASCO Publications
ascopubs.org
May 20, 2025 at 1:28 PM
Use of Large Language Models in Clinical Cancer Research | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10....
📣 Have something to report on an ongoing clinical trial? #JCOOA now accepting Trials in Progress articles! Read the first one here:
SWOG 2308: Randomized Phase III Study of Mosunetuzumab vs. Rituximab for Low–Tumor Burden Follicular Lymphoma ascopubs.org/doi/10.1200/...
SWOG 2308: Randomized Phase III Study of Mosunetuzumab vs. Rituximab for Low–Tumor Burden Follicular Lymphoma ascopubs.org/doi/10.1200/...
SWOG 2308: Randomized Phase III Study of Mosunetuzumab Versus Rituximab for Low–Tumor Burden Follicular Lymphoma | JCO Oncology Advances
ascopubs.org
April 28, 2025 at 3:58 PM
📣 Have something to report on an ongoing clinical trial? #JCOOA now accepting Trials in Progress articles! Read the first one here:
SWOG 2308: Randomized Phase III Study of Mosunetuzumab vs. Rituximab for Low–Tumor Burden Follicular Lymphoma ascopubs.org/doi/10.1200/...
SWOG 2308: Randomized Phase III Study of Mosunetuzumab vs. Rituximab for Low–Tumor Burden Follicular Lymphoma ascopubs.org/doi/10.1200/...
In the latest episode of JCO OP: Put Into Practice, @fumikochino.bsky.social talks with Dr. Atif Khan and Dr. Lola Fayanju about treatment de-escalation in patients with breast cancer.
ascopubs.org/do/treatment...
ascopubs.org/do/treatment...
Treatment De-escalation for Favorable Risk Breast Cancer | Podcast | ASCO Publications
Dr. Chino talks with Dr. Atif Khan and Dr. Lola Fayanju about the shift in breast cancer management from reducing locoregional recurrence and improving breast cancer mortality to deintensification, sh...
ascopubs.org
April 24, 2025 at 5:52 PM
In the latest episode of JCO OP: Put Into Practice, @fumikochino.bsky.social talks with Dr. Atif Khan and Dr. Lola Fayanju about treatment de-escalation in patients with breast cancer.
ascopubs.org/do/treatment...
ascopubs.org/do/treatment...
Educational Video as an Alternative to Pretest In-Person Genetic Counseling in Candidates for Cancer Genetic Testing: A Randomized Controlled Noninferiority Trial | JCO Oncology Practice ascopubs.org/doi/10.1200/...
Educational Video as an Alternative to Pretest In-Person Genetic Counseling in Candidates for Cancer Genetic Testing: A Randomized Controlled Noninferiority Trial | JCO Oncology Practice
PURPOSEThe purpose ot this study was to assess the effectiveness of an educational video
compared to in-person genetic counseling for cancer genetic testing candidates. Genetic
cancer risk assessment ...
ascopubs.org
April 11, 2025 at 4:25 PM
Educational Video as an Alternative to Pretest In-Person Genetic Counseling in Candidates for Cancer Genetic Testing: A Randomized Controlled Noninferiority Trial | JCO Oncology Practice ascopubs.org/doi/10.1200/...
Reposted by Emilie Gunn
Reposted by Emilie Gunn
Navigating a change from self-publishing, independent publishing, or a commercial publisher can be tenuous and fraught. Join Adam Etkin and Susan Willner at 12 PM ET as we discuss how to plan for an effective publisher move! Register NOW: www.councilscienceeditors.org/cse-connect
March 25, 2025 at 1:24 PM
Navigating a change from self-publishing, independent publishing, or a commercial publisher can be tenuous and fraught. Join Adam Etkin and Susan Willner at 12 PM ET as we discuss how to plan for an effective publisher move! Register NOW: www.councilscienceeditors.org/cse-connect
Early Bird registration is ending soon for the @councilscienceed.bsky.social annual meeting. Join us in Minneapolis May 3-6!
Planning to join us from May 3-6 in Minneapolis? Time is running out for you to get the best deal! Register before March 31 to secure Early Bird Pricing 🐦
Before you book your travel, check out the schedule to see all #CSEMinneapolis has to offer: cse.memberclicks.net/annual-meeti...
Before you book your travel, check out the schedule to see all #CSEMinneapolis has to offer: cse.memberclicks.net/annual-meeti...
March 21, 2025 at 2:31 PM
Early Bird registration is ending soon for the @councilscienceed.bsky.social annual meeting. Join us in Minneapolis May 3-6!
Large Language Models as Decision-Making Tools in Oncology: Comparing Artificial Intelligence Suggestions and Expert Recommendations | JCO Clinical Cancer Informatics ascopubs.org/doi/10.1200/...
Large Language Models as Decision-Making Tools in Oncology: Comparing Artificial Intelligence Suggestions and Expert Recommendations | JCO Clinical Cancer Informatics
PURPOSETo determine the accuracy of large language models (LLMs) in generating appropriate
treatment options for patients with early breast cancer on the basis of their medical
records.MATERIALS AND M...
ascopubs.org
March 21, 2025 at 2:29 PM
Large Language Models as Decision-Making Tools in Oncology: Comparing Artificial Intelligence Suggestions and Expert Recommendations | JCO Clinical Cancer Informatics ascopubs.org/doi/10.1200/...
🎙️In the latest #JCOOP podcast, @fumikochino.bsky.social discusses the past, present, and future of prior authorization in cancer care with Dr. Michael Anne Kyle, a health policy expert with a research focus on utilization management and patient burdens from prior auth. 🎧
ascopubs.org/do/prior-aut...
ascopubs.org/do/prior-aut...
Prior Authorization: How Did We Get Here and Where Are We Going? | ASCO Publications
Dr. Chino discusses the past, present, and future of prior authorization in cancer care with Dr. Michael Anne Kyle, a health policy expert with a research focus on utilization management and patient b...
ascopubs.org
March 20, 2025 at 3:16 PM
🎙️In the latest #JCOOP podcast, @fumikochino.bsky.social discusses the past, present, and future of prior authorization in cancer care with Dr. Michael Anne Kyle, a health policy expert with a research focus on utilization management and patient burdens from prior auth. 🎧
ascopubs.org/do/prior-aut...
ascopubs.org/do/prior-aut...